Correlation Between Agios Pharm and Travere Therapeutics
Can any of the company-specific risk be diversified away by investing in both Agios Pharm and Travere Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Agios Pharm and Travere Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Agios Pharm and Travere Therapeutics, you can compare the effects of market volatilities on Agios Pharm and Travere Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Agios Pharm with a short position of Travere Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Agios Pharm and Travere Therapeutics.
Diversification Opportunities for Agios Pharm and Travere Therapeutics
0.48 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Agios and Travere is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Agios Pharm and Travere Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Travere Therapeutics and Agios Pharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Agios Pharm are associated (or correlated) with Travere Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Travere Therapeutics has no effect on the direction of Agios Pharm i.e., Agios Pharm and Travere Therapeutics go up and down completely randomly.
Pair Corralation between Agios Pharm and Travere Therapeutics
Given the investment horizon of 90 days Agios Pharm is expected to generate 1.03 times more return on investment than Travere Therapeutics. However, Agios Pharm is 1.03 times more volatile than Travere Therapeutics. It trades about 0.38 of its potential returns per unit of risk. Travere Therapeutics is currently generating about 0.11 per unit of risk. If you would invest 4,487 in Agios Pharm on September 2, 2024 and sell it today you would earn a total of 1,452 from holding Agios Pharm or generate 32.36% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Agios Pharm vs. Travere Therapeutics
Performance |
| Timeline |
| Agios Pharm |
| Travere Therapeutics |
Agios Pharm and Travere Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Agios Pharm and Travere Therapeutics
The main advantage of trading using opposite Agios Pharm and Travere Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Agios Pharm position performs unexpectedly, Travere Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Travere Therapeutics will offset losses from the drop in Travere Therapeutics' long position.| Agios Pharm vs. Mereo BioPharma Group | Agios Pharm vs. Blueprint Medicines Corp | Agios Pharm vs. Day One Biopharmaceuticals | Agios Pharm vs. Biomarin Pharmaceutical |
| Travere Therapeutics vs. Tff Pharmaceuticals | Travere Therapeutics vs. Eliem Therapeutics | Travere Therapeutics vs. Inhibrx | Travere Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |